Evaluation of the effect of Gastrojejunal anastomosis diameter on weight loss outcomes, Reflux and damping syndrome during ?months follow up
Phase 3
Recruiting
- Conditions
- Condition 1: Reflux. Condition 2: Dumping.Gastro-esophageal reflux diseasePostgastric surgery syndromesK91.1
- Registration Number
- IRCT20190128042520N6
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Age:18-65 year
OAGB surgery
BMI 40-50
Exclusion Criteria
Revision surgery
Presence of hiatal hernia of any size
Grade D or Barrett's reflux esophagitis
Pregnancy during the study period
Smoking, alcohol and NSAIDs
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reflux. Timepoint: Before surgery - 6 months after surgery. Method of measurement: ?Endoscopy_ GERD score questionaire.;Dumping. Timepoint: Six months after surgery. Method of measurement: Dumping questionaire.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does anastomosis diameter in IRCT20190128042520N6 influence gastric emptying rates and ghrelin secretion post-surgery?
What are the comparative effectiveness outcomes of IRCT20190128042520N6 vs standard Roux-en-Y gastric bypass for reflux and dumping syndrome?
Which biomarkers in IRCT20190128042520N6 predict weight loss success and postoperative complication risk in bariatric patients?
What adverse events are associated with different anastomosis diameters in IRCT20190128042520N6 and how are they managed?
How does IRCT20190128042520N6's anastomosis diameter strategy compare to pharmacological interventions for postgastric surgery syndromes?